Predictors of treatment response trajectories to cognitive behavioral therapy for chronic fatigue syndrome: A cohort study.
Van Oudenhove, Lukas, Debyser, Soetkin, Vergaelen, Elfi et al. · Journal of psychosomatic research · 2024 · DOI
Quick Summary
This study followed 297 people with ME/CFS who received cognitive behavioral therapy (CBT) to see how their fatigue improved over time. Researchers found that people responded very differently to treatment: some improved significantly, some improved a little, and some didn't improve at all. People who started treatment with higher anxiety, depression, stress, and physical symptoms—and lower mood—were less likely to benefit from CBT.
Why It Matters
This research helps clinicians and patients understand why CBT works better for some people with ME/CFS than others, potentially allowing earlier identification of patients who may need alternative or additional treatments. Identifying that anxiety reduction may precede fatigue improvement could inform treatment sequencing strategies.
Observed Findings
Four distinct fatigue trajectory subgroups were identified, with only 9% of patients showing strong improvement
Higher pre-treatment anxiety, depression, somatic symptoms, and perceived stress predicted membership in the 'no improvement' group
Reductions in anxiety symptoms preceded reductions in fatigue during treatment
The relationship between depressive symptoms and fatigue was bidirectional, while anxiety reduction more clearly preceded fatigue improvement
On average, patients showed statistically significant fatigue reduction over 15 CBT sessions, masking substantial individual variation
Inferred Conclusions
CBT produces heterogeneous responses in ME/CFS, with psychological symptom burden at baseline predicting poor treatment outcomes
Anxiety may be a treatment target that, when reduced, facilitates fatigue improvement
Depression and fatigue appear mutually reinforcing during CBT, rather than one causing the other
Patients with high baseline psychological distress may require enhanced or alternative treatment approaches beyond standard CBT
Remaining Questions
What mechanisms explain why anxiety reduction precedes fatigue improvement, and can targeting anxiety earlier in treatment improve overall outcomes?
What This Study Does Not Prove
This study cannot establish whether baseline symptoms directly cause poor treatment response or whether other unmeasured factors influence both symptom severity and treatment response. The cross-lagged models suggest temporal associations but cannot definitively prove causality. The findings are specific to CBT and may not generalize to other treatments for ME/CFS.
Tags
Symptom:Cognitive DysfunctionFatigue
Method Flag:PEM Not DefinedWeak Case DefinitionNo ControlsExploratory Only
Why do only 9% of patients achieve strong improvement with CBT, and what patient or treatment characteristics distinguish this group?
Would treatment modifications (intensity, sequencing, or integration with other therapies) improve response rates for the 'no improvement' and 'weak improvement' groups?
How do these treatment response patterns differ across ME/CFS patient subgroups defined by biomarkers, disease duration, or post-exertional malaise severity?